Literature DB >> 25232510

Omental transplantation for neurodegenerative diseases.

Hernando Rafael1.   

Abstract

Up to date, almost all researchers consider that there is still no effective therapy for neurodegenerative diseases (NDDs) and therefore, these diseases are incurable. However, since May 1998, we know that a progressive ischemia in the medial temporal lobes and subcommissural regions can cause Alzheimer's disease; because, in contrast to this, its revascularization by means of omental tissue can cure or improve this disease. Likewise we observed that the aging process, Huntington's disease, Parkinson's disease, and Amyotrophic lateral sclerosis; all of them are of ischemic origin caused by cerebral atherosclerosis, associated with vascular anomalies and/or environmental chemicals. On the contrary, an omental transplantation on the affected zone can stop and improve these diseases. For these reasons, I believe that NDDs, are wrongly classified as neurodegenerative disorders.

Entities:  

Keywords:  Aging; Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; omental transplantation

Year:  2014        PMID: 25232510      PMCID: PMC4162586     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  106 in total

1.  Cerebral atherosclerosis and oxidative stress in Alzheimer's disease.

Authors:  Hernando Rafael
Journal:  J Alzheimers Dis       Date:  2003-12       Impact factor: 4.472

2.  Hypothalamic ischemia and premature aging.

Authors:  Hernando Rafael
Journal:  Med Sci Monit       Date:  2007-07

3.  [Surgical technic of injecting autologous adrenal medullary tissue into the caudate nucleus for the treatment of Parkinson disease].

Authors:  I Madrazo; R Drucker-Colín; M Madrazo; A Zárate; V León; C Torres; P Reyes
Journal:  Gac Med Mex       Date:  1988 Sep-Oct       Impact factor: 0.302

4.  [Termino-terminal vascular microanastomosis by invagination].

Authors:  H R Cruz; E López; J Méndez Heredia; F Rubio Díaz
Journal:  Salud Publica Mex       Date:  1986 Mar-Apr

5.  A comparative study of cerebral atherosclerosis in males and females.

Authors:  G C Flora; A B Baker; R B Loewenson; A C Klassen
Journal:  Circulation       Date:  1968-11       Impact factor: 29.690

6.  Psychiatric disorders in neurocysticercosis.

Authors:  A R Tavares
Journal:  Br J Psychiatry       Date:  1993-12       Impact factor: 9.319

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Omental transplantation for epilepsy.

Authors:  H Rafael; R Mego
Journal:  J Neurosurg       Date:  2001-09       Impact factor: 5.115

9.  Neurogenesis in the postnatal human epileptic brain.

Authors:  Jorge A González-Martínez; William E Bingaman; Steven A Toms; Imad M Najm
Journal:  J Neurosurg       Date:  2007-09       Impact factor: 5.115

10.  Regional anatomic and age effects on cell function of human adipose-derived stem cells.

Authors:  Bret M Schipper; Kacey G Marra; Wei Zhang; Albert D Donnenberg; J Peter Rubin
Journal:  Ann Plast Surg       Date:  2008-05       Impact factor: 1.539

View more
  5 in total

Review 1.  Omental transplantation for neuroendocrinological disorders.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2015-09-10

2.  Etiology and treatment of amyotrophic lateral sclerosis.

Authors:  Hernando Rafael; Juan Oscar David; Antonio Santiago Vilca
Journal:  Am J Neurodegener Dis       Date:  2017-04-15

3.  Omental transplantation in a patient with mild ALS.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2016-07-06

Review 4.  The Role of the Craniocervical Junction in Craniospinal Hydrodynamics and Neurodegenerative Conditions.

Authors:  Michael F Flanagan
Journal:  Neurol Res Int       Date:  2015-11-30

Review 5.  Circadian Rhythm and Alzheimer's Disease.

Authors:  Jan Homolak; Monika Mudrovčić; Barbara Vukić; Karlo Toljan
Journal:  Med Sci (Basel)       Date:  2018-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.